Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
N04AA02 - BiperidenATC-DDD Version 2016. Source: WHO
N - Nervous System
N04 - Anti-Parkinson Drugs

This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.

The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.
No separate DDDs are established for oral depot formulations.

N04A - Anticholinergic Agents
N04AA - Tertiary Amines
N04AA02 - Biperiden
2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home